These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10088075)

  • 21. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Mikhailidis DP; Barradas MA; Dandona P
    J R Soc Med; 1987 Jan; 80(1):61. PubMed ID: 3560134
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ;
    Circulation; 2006 Dec; 114(24):2710-38. PubMed ID: 17130340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.
    Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM
    Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyslipidemias in the elderly].
    Schils E
    Rev Med Brux; 2001 Sep; 22(4):A338-40. PubMed ID: 11680198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyslipidemia and its management after renal transplantation.
    Andany MA; Kasiske BL
    J Nephrol; 2001; 14 Suppl 4():S81-8. PubMed ID: 11798152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [44. Normalizing blood lipids--with diet, sports and antilipemic agents].
    Faust M; Krone W
    MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipid metabolism disorders: diagnosis and treatment. 1. Prevalence of hyperlipidemias and other cardiovascular risk factors. National Cholesterol Initiative].
    Fortschr Med; 1991 Apr; 109(13):288-90. PubMed ID: 2066046
    [No Abstract]   [Full Text] [Related]  

  • 28. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
    J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New guidelines for screening and management of familial dyslipidemia].
    Brun N; Aubert CE; Nanchen D; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):435-9. PubMed ID: 27089599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia.
    Sibley C; McGann S; Stone NJ
    Am J Cardiol; 2004 Sep; 94(5):699-700. PubMed ID: 15342318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Summary of 'Cholesterol' guideline (first revision) of the Dutch Society of Family Physicians].
    van der Laan JR; Thomas S
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):421-7. PubMed ID: 10719546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial hypercholesterolemia in eastern Quebec: a public health problem? The experience of the hyperlipidemia clinic of Chicoutimi].
    Gaudet D; Tremblay G; Perron P; Gagné C; Ouadahi Y; Moorjani S
    Union Med Can; 1995 Sep; 124(2):54-60. PubMed ID: 8846258
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipid-lowering therapy in chronic kidney disease].
    Fernández-Vega F
    Nefrologia; 2004; 24 Suppl(6):113-26, 187-235. PubMed ID: 15696902
    [No Abstract]   [Full Text] [Related]  

  • 34. [The program for detection and treatment of patients with familial hypercholesterolemia (MedPed FH) in the Czech Republic].
    Freiberger T; Soska V; Kuhrová V; Stejskal J
    Cas Lek Cesk; 2000 Apr; 139(7):195-6. PubMed ID: 10916204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The management of familial hyperlipidemia diagnosed in childhood].
    de Gennes JL; Loison J
    Ann Pediatr (Paris); 1989 Nov; 36(9):611-4. PubMed ID: 2589777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dyslipidemias and cardiovascular diseases: towards a new perspective].
    Darioli R; Depairon M; Perdrix J; Mooser V
    Rev Med Suisse Romande; 2002 Oct; 122(10):489-93. PubMed ID: 12494781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consideration of serum cholesterol in risk factor profiling for all young individuals.
    Berenson GS; Srinivasan SR
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():1-9. PubMed ID: 12063769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular prevention: recommendations for approaching the vascular risk associated with dyslipidemia].
    da Silva PM; Silva JM; Gil VM;
    Rev Port Cardiol; 2002 Oct; 21(10):1201-9. PubMed ID: 12522982
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease risk.
    Himmelmann A; Kjeldsen S; Hedner T
    Blood Press; 2004; 13(3):125-6. PubMed ID: 15223719
    [No Abstract]   [Full Text] [Related]  

  • 40. [How I treat diabetic dyslipemia in the framework of preventing cardiovascular pathology].
    Berthezène F; Bernard S
    Journ Annu Diabetol Hotel Dieu; 1997; ():237-44. PubMed ID: 9296979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.